Acer Therapeutics Inc. (ACER:NASDAQ) soared at $3.85, a gain of 34.6%. On Thu 14 Jan 21, ACER:NASDAQ hit a New 2-Week Intraday High of $2.96. The stock got featured on our News Catalysts scanner on Thu 17 Dec 20 at 11:11 AM in the 'BIOTECH' category. From Thu 31 Dec 20, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Fri 07 Aug 20 at $5.84 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About Acer Therapeutics Inc. (ACER:NASDAQ)
Acer Therapeutics Inc is a pharmaceutical company that acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need.
Top 10 Gainers:
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 76.9%
- ObsEva SA (OBSV:NASDAQ), 61.51%
- Ceragon Networks Ltd. (CRNT:NASDAQ), 53.97%
- DBV Technologies S.A. (DBVT:NASDAQ), 51.34%
- Charah Solutions, Inc. (CHRA:NYSE), 42.07%
- Atlantic Power Corporation (AT:NYSE), 39.05%
- Acer Therapeutics Inc. (ACER:NASDAQ), 34.62%
- KSPN (KSPN:NASDAQ), 33.98%
- Avinger, Inc. (AVGR:NASDAQ), 32.43%
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 31.67%